... examined with the use of fluorescence microscopy for PKH26 dye The sections were stained for hematoxylin and eosin Immunohistochemistry was performed for asarcomeric actin, von Willebrand factor ... Kit (Applied Biosystems, Foster City, CA, USA) was performed for cDNA synthesis The cycling parameters were 25°C for 10 minutes and 37°C for hours Page of 10 Real time RT-PCR analyses were used ... 2.41%, respectively; p < 0.001; Figure 7) Discussion Cell therapy may be an alternative treatment for heart failure The optimal cell for transplantation and the source of the cells to be isolated...
Ngày tải lên: 10/08/2014, 09:21
... to start cholesterol-lowering therapy in patients with coronary heart disease A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction Circulation ... eligible for this study Patients were identified as having IHD if they had an ICD-9-CM code of 410.xx (acute myocardial infarction), 411.xx (other acute and subacute forms of ischemic heart disease) , ... with coronary heart disease who not undergo lipid testing Am J Cardiol 2003, 91:986-8, A7 Pineros SL, Sales AE, Li YF, Sharp ND: Improving care to patients with ischemic heart disease: experiences...
Ngày tải lên: 11/08/2014, 05:21
báo cáo khoa học: " Implementing electronic clinical reminders for lipid management in patients with ischemic heart disease in the veterans health administration: QUERI Series" ppsx
... to start cholesterol-lowering therapy in patients with coronary heart disease A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction Circulation ... eligible for this study Patients were identified as having IHD if they had an ICD-9-CM code of 410.xx (acute myocardial infarction), 411.xx (other acute and subacute forms of ischemic heart disease) , ... with coronary heart disease who not undergo lipid testing Am J Cardiol 2003, 91:986-8, A7 Pineros SL, Sales AE, Li YF, Sharp ND: Improving care to patients with ischemic heart disease: experiences...
Ngày tải lên: 11/08/2014, 16:21
Advances in StentTherapy for Ischaemic Heart Disease
... Pharmacologic agent Mak Heart Drug-eluting Stent Drug carrier vehicle Stent Platform Optimal Geometry “Closed Cell” “Open Cell” 1.0 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 Mak Heart Stent-based Drug ... Mak Heart Popma J TAXUS IV Angiographic Results 2003 2.50 Late Loss: TLR Probability for TLR 1.0 Late loss
Ngày tải lên: 26/01/2013, 11:02
Tài liệu Novel Strategies in Ischemic Heart Disease Edited by Umashankar Lakshmanadoss pdf
... Conditions of Diastolic Heart Failure Suffered by Coronary Heart Disease Patients E.P Tatarchenko, N.V Pozdnyakova, O.E Morozova and E.A Petrushin 81 Pharmacotherapy of Ischemic Heart Disease 99 Chapter ... bedside and beyond” in the field of ischemic heart disease With increasing life expectancy and increasing prevalence of the disease, patients with ischemic heart disease are being taken care of by ... ever-increasing number of incidences of ischemic heart disease In recent years we have seen remarkable advances in the understanding of ischemic heart disease in areas such as epidemiology, risk...
Ngày tải lên: 20/02/2014, 08:20
Ischemic Heart Disease Edited by David C. Gaze doc
... complications following AMI 124 Other acute ischemic heart diseases 125 Chronic ischemic heart disease Diseases Database (DiseaseDB) 8695 - Ischemic or Ischaemic Heart disease, Myocardial Medical Object ... Introduction to Ischemic Heart Disease http://dx.doi.org/10.5772/55248 Epidemiology of ischemic heart disease According to the World Health Organisation, chronic diseases of which heart disease is ... all encompassing umbrella of cardiovascular disease and the Pathobiology of ischemic heart disease (IHD) The epidemiological burden of Ischemic heart disease is described on a global scale; followed...
Ngày tải lên: 16/03/2014, 21:20
NOVEL STRATEGIES IN ISCHEMIC HEART DISEASE pot
... Conditions of Diastolic Heart Failure Suffered by Coronary Heart Disease Patients E.P Tatarchenko, N.V Pozdnyakova, O.E Morozova and E.A Petrushin 81 Pharmacotherapy of Ischemic Heart Disease 99 Chapter ... bedside and beyond” in the field of ischemic heart disease With increasing life expectancy and increasing prevalence of the disease, patients with ischemic heart disease are being taken care of by ... ever-increasing number of incidences of ischemic heart disease In recent years we have seen remarkable advances in the understanding of ischemic heart disease in areas such as epidemiology, risk...
Ngày tải lên: 27/06/2014, 11:20
BỆNH TIM DO THIẾU MÁU CỤC BỘ (ISCHEMIC HEART DISEASE) Phần 2 21 / BỆNH NHÂN VỚI pot
... hay xuyên thành ) gồm có điều trị với thuốc làm tan huyết khối đường tĩnh mạch ( iv thrombolytic therapy ) nơi tất bệnh nhân nhập viện vòng 12 kể từ khởi đầu triệu chứng ( chống định ) Những chống ... di não biết AVM phình mạch não 27/ NÓI RÕ CÁC CHỈ ĐỊNH CỦA LIỆU PHÁP TÁI TƯỚI MÁU (REPERFUSION THERAPY) TRONG NHỒI MÁU CƠ TIM - Đoạn ST nâng cao 1mm hai dérivation - Cơn đau không đáp ứng với ... TƯỚI MÁU NÀO ĐƯỢC ƯA THÍCH TRONG NHỒI MÁU CƠ TIM CẤP TÍNH ? Điều trị tan huyết khối ( thrombolytic therapy ) so với phẫu thuật tạo mạch nguyên khởi ( primary angioplasty ) : Phẫu thuật tạo mạch thực...
Ngày tải lên: 13/07/2014, 20:20
BỆNH TIM DO THIẾU MÁU CỤC BỘ (ISCHEMIC HEART DISEASE) Phần 1 docx
... TÍNH CÓ NHỮNG TRIỆU CHỨNG NHƯ THỂ NÀO ? Triệu chứng thông thường đau vùng ngực (central chest comfort) Cơn đau cảm thấy ( theo thứ tự hay gặp giảm dần ) ngực phải trái, vai cánh tay phải trái, ... TRÊN ĐIỆN TÂM ĐỒ ? Những thay đổi bất thường đoạn ST không biểu thương tổn tim thiếu máu cục ( ischemic cardiac injury) Dòng điện thương tổn (current of injury) kèm nhồi máu tim với nâng cao...
Ngày tải lên: 13/07/2014, 20:20
BỆNH TIM DO THIẾU MÁU CỤC BỘ (ISCHEMIC HEART DISEASE) pptx
... TRIỆU CHỨNG KHÁC LIÊN KẾT VỚI CƠN ĐAU THẮT NGỰC TRONG BỆNH TIM DO THIẾU MÁU CỤC BỘ (ICHEMIC HEART DISEASE) ? Khó thở thường kèm đau thắt ngực Nhiều tình trạng bệnh lý khác với đau thắt ngực gây ... TÍNH CÓ NHỮNG TRIỆU CHỨNG NHƯ THỂ NÀO ? Triệu chứng thông thường đau vùng ngực (central chest comfort) Cơn đau cảm thấy (theo thứ tự hay gặp giảm dần) ngực phải trái, vai cánh tay phải trái, họng ... ST TRÊN ĐIỆN TÂM ĐỒ ? Những thay đổi bất thường đoạn ST không biểu thương tổn tim thiếu máu cục (ischemic cardiac injury) Dòng điện thương tổn (current of injury) kèm nhồi máu tim với nâng cao...
Ngày tải lên: 26/07/2014, 18:20
Báo cáo y học: "Role of vasopressin in the treatment of anaphylactic shock in a child undergoing surgery for congenital heart disease: a case report" docx
... induction vital signs were stable: SAP 80/ 40 mmHg, heart rate (HR) 110 beats/min, SatO2 98%, CVP mmHg, EtCO2 34 mmHg, cSvO2 80% Antibiotic therapy (amoxicillin/clavulanate potassium) and methylprednisolone ... (amoxicillin/clavulanate potassium) and methylprednisolone (30 mg/kg) were administered as routine before sternotomy incision Before starting cardiopulmonary bypass (CPB), 380 UI/kg of heparin were given and after ... plasma lactate levels (5.1 mmol/L) When vital parameters seemed adequately stable, the surgical procedure was performed with a CPB time of 25 minutes During this time, the epinephrine infusion could...
Ngày tải lên: 11/08/2014, 11:20
báo cáo khoa học: " Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling" ppt
... additional requirement that proteins were quantified for at least two of the pool pairs for a disease, 346 proteins for CHD and 366 proteins for stroke were included in statistical analyses Of ... while Table provides this information for the corresponding subset of Table Five of the proteins having a FDR < 0.05 for disease association are influenced by hormone therapy In addition to these, ... Ratios for these protein groups were logarithmically transformed and median-centered at zero for each IPAS experiment Groups that had fewer than four peptide ratios across all experiments for a...
Ngày tải lên: 11/08/2014, 12:20
Báo cáo y học: "Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease" ppt
... PCI Statistics The data were analyzed with the Statistical Package for Social Sciences (SPSS 11.0 for Windows, Munich Germany) For comparison of several groups the Mann-Whitney U Test was used ... lumen losstherapy Late lumen loss in patients without obstructive sleep apnea, OSA patients without treatment and OSA patients with effective CPAP therapy The predominant target vessel for intervention ... cognition, insomnia or cardiovascular disease [26] Futhermore, recent studies support a protective effect of CPAP therapy with regard to death from cardiovascular disease in patients with OSA [27]...
Ngày tải lên: 12/08/2014, 15:21
Transplantation of skeletal myoblast in ischemic heart disease 1
... Introduction Section I: Ischemic heart disease 1.1.1 Introduction to ischemic heart disease (IHD) 1.1.2 Current status on IHD treatment 1.1.3 No-option patients: a target population for cell therapy 1.1.4 ... enhanced the survival of transplanted SkMs and improved heart performance Even in autologous groups, cyclosporine does enhance the heart performance This study enabled us a better understanding ... National Heart Center, for kind technique assistance in heart function analysis by echocardiography Special thanks go to associate professor Teh Ming, National University Hospital, for providing...
Ngày tải lên: 12/09/2015, 08:16
Transplantation of skeletal myoblast in ischemic heart disease 2
... procedures were performed in USA alone (Heart Disease and Stroke Statistics Updates 2006, American Heart Association) PCI is the most common treatment option for single vessel disease as well as ... longer candidates for PCI or CABG, or have exhausted or failed these modalities A significant number of patients (5-21%) with ischemic heart disease are not optimal candidates for revascularization ... for cell delivery in heart cell therapy The goal of any cell delivery strategy is to achieve the ideal concentration of viable cells for cardiac repair with the lowest risk to patients Therefore,...
Ngày tải lên: 12/09/2015, 08:16
Báo cáo y học: "Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome"
... Med Sci 2010, with APS We therefore compared single antiplatelet therapy and a combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with ... American Heart Association (APASS) [3] for prevention of stroke in patients with ischemic stroke or transient ischemic attack and with antiphospholipid antibodies (aPL), antiplatelet therapy is ... ischemic stroke Annual Review 2004; 1: 139-51 Sacco RL, Adams R, Albers G, et al Guideline for prevention of stroke in patients with ischemic stroke or transient ischemic attack A statement for...
Ngày tải lên: 26/10/2012, 09:48
The Use of Selected Medicinal Herbs for Chemoprevention and Treatment of Cancer, Parkinson’s Disease, Heart Disease, and Depression
... combination with other heart drugs, such as calcium-channel blockers or beta-adrenergic antagonists, as adjunctive therapy for heart rate control of chronic atrial fibrillation without heart failure or ... the standard therapy for heart failure (Hauptman and Kelly, 1999) In the future, there might be other uses for digitoxin There is evidence that digitoxin might have utility in cancer therapy Recent ... risk of aging, chronic disease, or cancer chemoprevention and treatment in the general population 11.3 Parkinson’s Disease Parkinson’s disease (also known as Parkinson disease or PD) is a degenerative...
Ngày tải lên: 25/10/2013, 05:20
Tài liệu Báo cáo Y học: Receptor crosstalk Implications for cardiovascular function, disease and therapy ppt
... hypertrophy Studies in animal disease models have provided important leads for the relevance of crosstalk in therapeutic management of heart failure, hypertension and ischemic heart diseases One of the ... A1-ADOmediated ischemic preconditioning and protection against apoptosis [80] In diseases with an element of pressure overload, such as hypertension or valvular heart diseases, the heart usually ... experimental heart failure and in human disease strongly argues for the existence of a1-AR as a purposeful and productive resource for adaptive regulation of contractility in response to cardiac disease...
Ngày tải lên: 21/02/2014, 15:20
Báo cáo khoa học: Active-site-specific chaperone therapy for Fabry disease Yin and Yang of enzyme inhibitors pptx
... DGJ for 140 days, indicating that DGJ is well tolerated in mice ASSC therapy for Fabry disease in humans The clinical proof-of-concept for ASSC therapy has been investigated in cardiac Fabry disease ... suffer from heart failure or end-stage renal failure [8] The prevalence of Fabry disease is estimated at : 40 000 for the classic form The incidence of the variant form of Fabry disease was found ... to Fabry disease, small molecules capable of specifically rescuing misfolded enzyme proteins have been identified for Gaucher disease [20,21], Tay-Sachs and Sandhoff disease [22] (details for Gaucher...
Ngày tải lên: 30/03/2014, 03:20
gene therapy for liver disease
... other hand, it is necessary for any vehicle used for in 156 GENE THERAPY FOR LIVER DISEASE vivo hepatic gene therapy to reach the liver efficiently For systemic application, the gene vectors are ... persistent infection and chronic disease of the liver and are serious threats to public health Gene therapy approaches to therapy are the 180 GENE THERAPY FOR LIVER DISEASE use of targeted antisense ... PRINCIPLES FOR HEPATIC GENE THERAPY 157 therapy is that only dividing cells are efficiently transduced To circumvent this problem, researchers have performed partial hepatectomies before the administration...
Ngày tải lên: 10/04/2014, 22:11